Synthesis and biological activity of 2,4-diamino-6- and -7-(1-adamantyl)pteridines.
D000230:Adenocarcinoma; D000588:Amines / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D001952:Bridged-Ring Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D002478:Cells, Cultured; D002855:Chromatography, Thin Layer; D003516:Cycloparaffins / Q000138:chemical synthesis* / Q000494:pharmacology; D003864:Depression, Chemical; D013293:Enterococcus faecalis / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D011621:Pteridines / Q000138:chemical synthesis* / Q000494:pharmacology; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship
D000588:Amines; D001952:Bridged-Ring Compounds; D003516:Cycloparaffins; D011621:Pteridines